Has anyone dealt with tirzepatide dual agonism: gip + glp-1 synergistic mechanism?

One thing that is still open after LibrarianMeg’s answer:

What did you change at the same time, and can you separate the two now?

BethLabQueen said:

One practical note: write down what you did and when, before you need it.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

Worth separating that from the pharmacology, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here.

BethLabQueen said:

One practical note: write down what you did and when, before you need it.

Saving this. It is the first explanation that did not require me to already understand it. Adding it to my notes with a link back to this thread.

From the other side of the consultation, briefly. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

That is the short version; the long version is somebody else's post.